evidoria

← Back to browse

Good practice Imported

BioInnovate Africa — Sida-Funded Regional Programme Turning Bioscience Research into Commercial Innovation Across East Africa

Kenya · Nairobi · See the Kenya profile · See the Nairobi profile

Top 50% 67/100 · Ask Evidence Copilot about this practice

Since 2010, Sida-funded BioInnovate Africa, hosted at icipe in Nairobi, has run three phases turning East African university bioscience research into commercial innovation, producing 54 new crop varieties and industrial wastewater systems that cut pollutants by 99%.

BioInnovate Africa — Sida-Funded Regional Programme Turning Bioscience Research into Commercial Innovation Across East Africa

Details

Promoter
BioInnovate Africa Programme (hosted by icipe), funded by Sida
Period
2010-present (Phase I 2010-2015, Phase II 2016-2021, Phase III ongoing)
Keywords
bioscience, agriculture, technology transfer, bioeconomy, regional development

Description

Launched in 2010 and evolved from the BioEARN research network founded in 1999, BioInnovate Africa is a regional programme funded by the Swedish International Development Cooperation Agency (Sida) and hosted at the International Centre of Insect Physiology and Ecology (icipe) in Nairobi, Kenya. It funds multi-country consortia of universities, industry and government agencies across Burundi, Ethiopia, Kenya, Rwanda, Tanzania and Uganda to convert bioscience research into commercial, bio-based innovations.
In Phase I (2010-2015), Sida committed roughly SEK 90 million (about USD 12 million) to nine consortia-based projects on crop improvement, agro-industrial waste use and bioscience innovation policy. The programme trained 7 PhD and 38 MSc students and developed 54 new crop varieties across sorghum, finger millet, cassava, sweet potato and potato. Industrial wastewater-treatment systems piloted at sites in Tanzania, Uganda and Ethiopia combined biodigestion with a constructed-wetland polishing step, achieving 99% removal of pollutants while capturing methane as biogas.
Sida renewed funding for Phase II (2016-2021) at SEK 100.7 million and has since committed up to SEK 160 million (about USD 17 million) for Phase III, which icipe describes as the largest single donor investment yet in regional bioscience research and innovation in Eastern Africa. An independent Phase II Review and Evaluation Report assessed programme performance and fed recommendations into the design of Phase III.
As a donor-dependent programme reliant on successive Sida funding renewals, BioInnovate Africa's continuity is not guaranteed beyond each funding cycle, and its publicly available evaluation material documents programmatic outputs — varieties developed, treatment systems piloted, students trained — more thoroughly than independently verified downstream income or adoption effects for farmers and firms.

Read the full analysis: https://bioinnovate-africa.org/program-summary/

Read the full analysis: https://bioinnovate-africa.org/

Implementation

Implementation detail (cost, timeline, staffing, conditions for success) is not yet available for this practice.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful